SCHEMBL7832452

SCHEMBL7832452

NS(=O)(=O)c1ccc(-c2nc(C(=O)Nc3cccc(F)c3)sc2-c2ccc(F)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.50
PTGS1 P23219 6/20 0.50
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ESR1 P03372 1/20 0.48
ESRRG P62508 1/20 0.48
CA2 P00918 5/20 0.48
CA1 P00915 4/20 0.48
CA4 P22748 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 2/20 0.46
CA12 O43570 1/20 0.46
ALDH1A1 P00352 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7845065 1.00 PTGS2 (0.50) PTGS2PTGS1LMNASMN1; SMN2ESR1
SCHEMBL7832860 0.91 PTGS2 (0.50) PTGS2PTGS1CA2CA1CA4
SCHEMBL7846576 0.91 PTGS2 (0.50) PTGS2PTGS1CA2CA1CA4
SCHEMBL7846064 0.91 PTGS2 (0.59) PTGS2PTGS1LMNASMN1; SMN2CA2
SCHEMBL7843501 0.91 PTGS2 (0.59) PTGS2PTGS1LMNASMN1; SMN2CA2
SCHEMBL7843989 0.91 PTGS2 (0.50) PTGS2PTGS1CA2CA1CA4
SCHEMBL7845746 0.91 PTGS2 (0.55) PTGS2PTGS1CA2CA1CA4
SCHEMBL7842841 0.91 PTGS2 (0.50) PTGS2PTGS1CA2CA1CA4
SCHEMBL7840455 0.91 PTGS2 (0.55) PTGS2PTGS1CA2CA1CA4
SCHEMBL7842507 0.90 ESR1 (0.61) PTGS2PTGS1ESR1ESRRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125932-A2 Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-22 EP disclosed
US-5668161-A Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 1997-09-16 US disclosed
EP-0772606-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003392-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed